Drug intelligence / Profile preview

polymerized grass pollen allergen extract

Development stage
Unknown
Lead developer
Inmunotek
Modality
Sublingual Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics, Subcutaneous Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics
Administration
Subcutaneous
01

Overview

Polymerized grass pollen allergen extract is a subcutaneous allergen immunotherapy (SCIT) product developed by Inmunotek. It consists of allergoids—allergens chemically modified with glutaraldehyde to form polymers. This modification reduces the extract's IgE-binding capacity, thereby improving safety by minimizing the risk of systemic allergic reactions, while maintaining the immunogenicity required for therapeutic efficacy. The product is derived from grass pollen species, specifically *Phleum pratense* (Timothy grass) and *Dactylis glomerata* (Orchard grass). In some formulations, the allergoids are conjugated with non-oxidized mannan from *Saccharomyces cerevisiae* to enhance targeting to dendritic cells. The primary mechanism of action is the induction of immune tolerance through the promotion of IL-10-producing regulatory T cells (Tregs). It is used to treat allergic rhinitis, allergic rhinoconjunctivitis, and mild-to-moderate asthma in patients sensitized to grass pollen.

Brand names
Clustek
Other names
polymerized grass pollen allergoidgrass pollen allergoid
02

Targets

IL10 (Interleukin-10)CLR (C-type lectin receptor)TCR (T cell antigen receptor complex)BCR (Immunoglobulin G B Cell Receptor)

Beyond the preview

Go deeper on polymerized grass pollen allergen extract.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on polymerized grass pollen allergen extract.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call